Walleye Capital LLC Intellia Therapeutics, Inc. Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 44,800 shares of NTLA stock, worth $438,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,800

Previous 22,500 99.11%

Holding current value

$438,591

Previous $503,000 82.9%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $313,035 - $434,312	15,874 Added 28.78%	71,029 $1.46 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $993,932 - $1.35 Million	49,647 Added 901.36%	55,155 $1.23 Million
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $4.71 Million - $6.49 Million	-197,819 Reduced 97.29%	5,508 $151,000
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $460,235 - $642,660	19,872 Added 10.83%	203,327 $6.2 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $5.8 Million - $8.4 Million	183,455 New	183,455 $5.8 Million
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $1.07 Million - $1.44 Million	32,080 Added 33.62%	127,504 $4.75 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $2.56 Million - $4.84 Million	77,163 Added 422.56%	95,424 $3.33 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $984,633 - $1.31 Million	18,261 New	18,261 $1.02 Million
Q2 2022 Aug 08, 2022	SELL	$38.49 - $76.21 $1.94 Million - $3.85 Million	-50,521 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $2.51 Million - $5.13 Million	43,147 Added 585.12%	50,521 $3.67 Million
Q4 2021 Mar 03, 2022	BUY	$100.76 - $138.36 $743,004 - $1.02 Million	7,374 New	7,374 $871,000
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $16,542 - $33,961	-1,485 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.44 - $15.58 $10,497 - $17,324	-1,112 Reduced 42.82%	1,485 $18,000
Q4 2019 Feb 14, 2020	SELL	$10.43 - $17.67 $9,637 - $16,327	-924 Reduced 26.24%	2,597 $38,000
Q3 2019 Nov 14, 2019	BUY	$13.07 - $18.51 $46,019 - $65,173	3,521 New	3,521 $47,000

Others Institutions Holding NTLA

# of Institutions

324

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $744M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Intellia Therapeutics, Inc. Transaction History